Tibet Weixinkang Medicine Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 347.030 million compared to CNY 299.929 million a year ago. Operating income was CNY 36.596 million compared to CNY 64.077 million a year ago. Net income was CNY 37.541 million compared to CNY 56.556 million a year ago. Basic earnings per share from continuing operations was CNY 0.09 compared to CNY 0.13 a year ago.